spacer
home > ict > autumn 2009 > electronic patient identification
PUBLICATIONS
International Clinical Trials

Electronic Patient Identification

 

THE NEED FOR CHANGE

Recruiting patients today for clinical trials is a high-touch, highcost business with many players and no economy of scale. Clinical trials are the gateway to revenue for the pharmaceutical, medical device and biotech industries, as pharmaceutical companies anticipate losing 33 per cent of their revenue in the next few years due to generics and drug patent expiry. Spending on R&D has grown by 37 per cent, from $51 billion in 2005 to $70 billion in 2009, while the number of new drug applications has dropped. It is clear that the development process must work faster and ensure that no product fails for lack of test subjects.

On average, difficulties in patient enrolment delay 81 per cent of all clinical trials from one to six months, costing pharmaceutical companies as much as $8 million each day (1). In addition, patient recruiting in 2009 will cost approximately $16 billion of the $70 billion to be spent on R&D, and require an average of 26 per cent of the time required for each trial. Recruiting reimbursement paid by the pharma industry to investigators ranges from $1,500 to over $10,000 per patient for trials requiring patients who are hard to locate. Existing methods of finding patient candidates include consumer market research, advertising and physician referrals – methods that are not meeting the needs for drug and medical device development and innovation.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
CEO and co-founder of KDH Systems, David Haddick has 25 years’ experience designing products in association with and for physicians, primarily in the field of medical imaging. While Vice President of Engineering for Dunn Instruments he produced a number of patented products, subsequently licensed by Fuji Medical, Japan. He then founded his own successful consulting practice which, for over 10 years, distributed a variety of US and European imaging products in Japan, and also developed and sold his own system of medical imaging cameras. Prior to founding KDH, David was Product Manager for CardioMatch diagnostic software for cardiology, and was instrumental in initiating and directing clinical trials at leading medical institutions worldwide. He holds a BSEE degree from the University of California, Berkeley.
spacer
David Haddick
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Appoints Lawrence Miller as Chief Technology Officer

LONDON & PHILADELPHIA – June 13, 2019: Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services. An accomplished innovator, Miller brings unique vision and expertise to a Signant team already committed to advancing clinical research with its next-generation technology portfolio.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement